In 2023, WuXi Biologics (Cayman) conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
In 2023, WuXi Biologics (Cayman) generated a total of 5,815 metric tonnes of waste.
Of this amount, 3.69% of WuXi Biologics (Cayman)'s total waste generated was recovered through methods such as recycling, reuse, or composting, while 96.31% was disposed of through landfilling, incineration, or combustion.
In 2023, WuXi Biologics (Cayman) reported a total waste generation of 5,815 metric tonnes, of which 3.69% was recovered through recycling, reuse, or composting. This low recovery rate highlights limited waste diversion and suggests that WuXi Biologics (Cayman) may be relying more heavily on landfill or incineration, underscoring opportunities for stronger resource recovery initiatives.
Since 2020, WuXi Biologics (Cayman)'s total waste generation increased by 55.73%, but declined by 3.23% in the year 2023, suggesting a potential shift toward more efficient material use or the early impact of waste reduction strategies.
Over the same period, WuXi Biologics (Cayman)'s waste recovery rate declined by 31.88%, yet improved by 24.79% in 2023, pointing to a recent rebound or renewed focus on better waste treatment outcomes.
Overall, WuXi Biologics (Cayman)’s waste generation and recovery data show a mixed and inconsistent trend. A deeper analysis of the company's activities, industry benchmarks, and operational changes is needed to assess its sustainability performance more precisely.
In 2023, WuXi Biologics (Cayman) generated a total of 5,815 metric tonnes of waste.
Of this amount, 49.05% of WuXi Biologics (Cayman)'s total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 50.95% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Since 2020, WuXi Biologics (Cayman)'s total waste generation increased by 55.73%, including a 3.23% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.
Over the same period, WuXi Biologics (Cayman) saw a long-term increase of 12.6% in hazardous waste share, but a 11.67% reduction in 2023, indicating a recent improvement that may reflect updated production inputs, enhanced treatment, or stricter controls.
Overall, WuXi Biologics (Cayman)'s waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.
In 2023, WuXi Biologics (Cayman) reported that 2,853 metric tonnes of its total waste output were classified as hazardous. This represents 49.05% of its overall waste generation.
The company treated this hazardous waste using a combination of methods. Only 1.91% of hazardous waste was recovered, meaning the vast majority was treated through disposal methods such as landfilling or incineration. This raises concerns about the environmental and health risks associated with WuXi Biologics (Cayman)’s current hazardous waste practices.